Peter Jüni
Peter Jüni
Director, AHRC, St. Michael's Hospital, and Professor of Medicine, University of Toronto
Bestätigte E-Mail-Adresse bei - Startseite
TitelZitiert vonJahr
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ...
BMJ 343, d5928, 2011
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
PG Steg, SK James, D Atar, LP Badano, C Blömstrom-Lundqvist, ...
European Heart Journal 33, 2551-67, 2012
2014 ESC/EACTS guidelines on myocardial revascularization
S Windecker, P Kolh, F Alfonso, JP Collet, J Cremer, V Falk, G Filippatos, ...
European Heart Journal 35 (37), 2541-2619, 2014
Assessing the quality of controlled clinical trials
P Jüni, DG Altman, M Egger
BMJ 323 (7303), 42-46, 2001
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
J Daemen, P Wenaweser, K Tsuchida, L Abrecht, S Vaina, C Morger, ...
The Lancet 369 (9562), 667-678, 2007
The hazards of scoring the quality of clinical trials for meta-analysis
P Jüni, A Witschi, R Bloch, M Egger
JAMA 282 (11), 1054-1060, 1999
Fractional flow reserve–guided PCI versus medical therapy in stable coronary disease
B De Bruyne, NHJ Pijls, B Kalesan, E Barbato, PAL Tonino, Z Piroth, ...
New England Journal of Medicine 367 (11), 991-1001, 2012
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial …
B Ibanez, S James, S Agewall, MJ Antunes, C Bucciarelli-Ducci, H Bueno, ...
European heart journal 39 (2), 119-177, 2017
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
L Wood, M Egger, LL Gluud, KF Schulz, P Jüni, DG Altman, C Gluud, ...
BMJ 336 (7644), 601-605, 2008
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
C Stettler, S Wandel, S Allemann, A Kastrati, MC Morice, A Schömig, ...
The Lancet 370 (9591), 937-948, 2007
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC …
H Baumgartner, V Falk, JJ Bax, M De Bonis, C Hamm, PJ Holm, B Iung, ...
European Heart Journal 38 (36), 2739-+, 2017
Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy
A Shang, K Huwiler-Müntener, L Nartey, P Jüni, S Dörig, JAC Sterne, ...
The Lancet 366 (9487), 726-732, 2005
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ...
bmj 355, i4919, 2016
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
S Trelle, S Reichenbach, S Wandel, P Hildebrand, B Tschannen, ...
BMJ 342, c7086, 2011
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
P Jüni, L Nartey, S Reichenbach, R Sterchi, PA Dieppe, M Egger
The Lancet 364 (9450), 2021-2029, 2004
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management …
ATF Members, SD Kristensen, J Knuuti, A Saraste, S Anker, HE Bøtker, ...
European heart journal 35 (35), 2383-2431, 2014
2018 ESC/ESH Guidelines for the management of arterial hypertension
B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ...
European heart journal 39 (33), 3021-3104, 2018
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ...
European Heart Journal 39 (3), 213-260, 2018
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
M Egger, P Juni, C Bartlett, F Holenstein, J Sterne
Health Technol Assess 7 (1), 1-76, 2003
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials
J Savović, HE Jones, DG Altman, RJ Harris, P Jüni, J Pildal, B Als-Nielsen, ...
Annals of internal medicine 157 (6), 429-438, 2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20